Victor Chin, MD
Ophthalmology · Seattle, WANPI 1174553010
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Johnson & Johnson Surgical Vision, Inc. accounts for 63.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,231 and has fallen 98.1% since, to $23 in 2021.
Across 22 payments — averaging $59.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$826
- Ivantis, Inc$150
- Alcon$103
- Bausch & Lomb, A Division Of Bausch Health US, LLC$86
- Kala Pharmaceuticals, Inc.$53
- Katena Products, Inc. (dba Corza Medical)$41
- plus $51 from 2 others
What the payments were for
- Consulting fees$15011%
- Travel & lodging$41632%
- Food & beverage$74557%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 9 | $826 |
| Ivantis, Inc | 1 | $150 |
| Alcon | 4 | $103 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $86 |
| Kala Pharmaceuticals, Inc. | 2 | $53 |
| Katena Products, Inc. (dba Corza Medical) | 1 | $41 |
| Carl Zeiss Meditec, Inc. | 1 | $32 |
| Novartis | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis 1-piece IOL$416
- Tecnis Multifocal Family of 1-piece IOLS$416
- Tecnis Symfony IOL$416
- Hydrus$150
- TECNIS Presbyopia-Correcting IOLs$124
How this compares
$1,311 in reported general payments places this provider in the 60th percentile of 428 ophthalmology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 260 | $9,746 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 156 | $2,872 |
| Latanoprost | 167 | $1,993 |
| Cyclosporine | 12 | $1,790 |
| Brimonidine Tartrate | 83 | $1,162 |
| Timolol Maleate | 44 | $747 |
| Travoprost | 13 | $682 |
| Dorzolamide Hcl | 21 | $377 |
| ErythromycinErythromycin Base | 22 | $295 |
| Diclofenac Sodium | 11 | $146 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Seattle
- Laura PerimanSeattle$1.7M
- Sheldon CowenSeattle$560K
- Jennifer ChaoSeattle$188K
- Debarshi MustafiSeattle$85K
- Michelle CabreraSeattle$75K
- Paul GriggsSeattle$62K
- Lisa Olmos de KooSeattle$50K
- Kathryn PeppleSeattle$29K
- Yewlin CheeSeattle$23K
- Miel SundararajanSeattle$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.